By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Canadian microarray-based diagnostics development firm SQI Diagnostics today reported that its net loss for its fiscal third quarter increased 50 percent year over year.

For the three months ended June 30, the Toronto-based company's loss was C$2.7 million (US$2.8 million), or C$.08 per share, compared to C$1.8 million, or C$.06 per share, a year ago.

The firm did not disclose any revenues for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.